BWI: Unichem Laboratories Ltd. Quarter 4 & FY 2013-14 – Financial Performance

Source : Unichem Laboratories Limited Monday, May 12, 2014 11:33AM IST (6:03AM GMT)   (BSE:506690)(NSE:UNICHEMLAB) Unichem Laboratories Ltd. Quarter 4 & FY 2013-14 – Financial Performance The Board of Directors of Unichem Laboratories Ltd at their meeting held on May 10, 2014 approved the Annual Audited Results for FY 2013-14   Mumbai, Maharashtra, India REVENUE   The Company’s standalone income from operations stood at Rs. 1,044.17 crs for year ending March 31, 2014 as against Rs. 1,005.21 crs recorded in the same period of previous year, reflecting a growth of 3.9 %. The Company’s consolidated income from operations stood at Rs. 1133.44 crs for year ending March 31, 2014 as against Rs. 1080.80 crs recorded in the same period of previous year, reflecting a growth of 4.87 %.  PBT & PAT   Standalone Profit Before Tax excluding Exceptional Items (Gain) for the year ended March 31, 2014 stood at Rs. 178.82 crs as compared to Rs. 162.44 crs in the same period last year. The Net Profit excluding Exceptional Items (Gain) for the year ended March 31, 2014 stood at Rs. 135.82 crs as against Rs. 129.59 crs in the same period last year. Net Profit margins excluding Exceptional Items (Gain) stood at 13 % as against 12.9% of the previous year. Consolidated Profit Before Tax excluding Exceptional Items (Gain) for the year ended March 31, 2014 stood at Rs. 171.16 crs as compared to Rs. 146.07 crs in the same period last year. The Net Profit excluding Exceptional Items (Gain) for the year ended March 31, 2014 stood at Rs. 128.16 crs as against Rs. 113.22 crs in the same period last year. Net Profit margins excluding Exceptional Items (Gain) stood at 11.31% as against % 10.48% of the previous year. The  stand alone EPS-Diluted excluding exceptional items (Gain) for the year ended March 31, 2014 stood at Rs. 14.94 (corresponding period in the previous year stood at Rs. 14.29). The  consolidated  EPS-Diluted excluding exceptional items (Gain) for the year ended March 31, 2014 stood at Rs. 14.10 (corresponding period in the previous year stood at Rs. 12.48). Exceptional  item net of tax amounting to Rs. 41.1 crs  represents profit on sale of Company’s manufacturing unit at SEZ, Indore and amortization of intangible assets due to change in their estimated useful life. Dividend   During the year, the Company has paid an interim dividend of Rs. 4/- (200%) per equity share of face value of Rs.2/-. Further the Board of Directors at its meeting held on May 10, 2014 has recommended a final dividend of Rs.4/- (200%), making it total dividend of Rs.8/- (400%) for the year ended 31st March 2014. Previous year dividend,   Rs. 4.50/- (225%).   About Unichem Laboratories Limited   Unichem Laboratories Limited is an International, integrated, specialty pharmaceutical Company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world. In India, the Company is a leaded in niche areas of cardiology, neurology and other orthopedics and anti-infectives. The Company has strong skills in product development, process chemistry and manufacturing of complex API as well as dosage forms. More information about the Company can be found at www.unichemlabs.com     Media Contact Details Rakesh Parikh, Unichem Laboratories Limited, ,+91 (22) 66888414 , rparikh@unichemlabs.com Monish Shah, Unichem Laboratories Limited, ,+91 (22) 66888509 , monish.shah@unichemlabs.com   KEYWORDS: Business/ Finance:Accounting & management, Business Services, Healthcare & biotechnology, Heavy industries, Major diversified industrial groups, Manufacturing Companies, Medical Devices, Pharmaceutical, Stock Exchanges   If you wish to change your Business Wire India selection please visit on Business Wire India and use your personal username and password to login.   Submit your press release at http://www.businesswireindia.com

Note : This is system generated mail. Please do not reply to it.